The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells

[1]  Yu Yan,et al.  Roles of microRNAs in cancer associated fibroblasts of gastric cancer. , 2017, Pathology, research and practice.

[2]  Jian-ning Chen,et al.  Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma. , 2017, Human pathology.

[3]  A. Ströse,et al.  Dysregulation of miRNA Expression in Cancer Associated Fibroblasts (CAFs) and Its Consequences on the Tumor Microenvironment , 2017, Cancers.

[4]  Mengwen Zhang,et al.  DNA methylation in the tumor microenvironment , 2017, Journal of Zhejiang University-SCIENCE B.

[5]  Su-zhan Zhang,et al.  Small role with big impact: miRNAs as communicators in the cross-talk between cancer-associated fibroblasts and cancer cells , 2017, International journal of biological sciences.

[6]  M. Carolan,et al.  The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis , 2017, Oncotarget.

[7]  Xia Li,et al.  MiR‐124 down‐regulation is critical for cancer associated fibroblasts‐enhanced tumor growth of oral carcinoma , 2017, Experimental cell research.

[8]  Hongwei Chen,et al.  MiR-15a-5p regulates viability and matrix degradation of human osteoarthritis chondrocytes via targeting VEGFA. , 2016, Bioscience trends.

[9]  Ming Yan,et al.  Cancer-associated fibroblasts promote cancer cell growth through a miR-7-RASSF2-PAR-4 axis in the tumor microenvironment , 2016, Oncotarget.

[10]  Y-L Teng,et al.  miRNA-15a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. , 2016, European review for medical and pharmacological sciences.

[11]  X. Xiang,et al.  mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance. , 2016, Oncology reports.

[12]  Shun-Fa Yang,et al.  The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies , 2016, Expert opinion on therapeutic targets.

[13]  C. Shuai,et al.  Downregulation of Microrna‐148a in Cancer‐Associated Fibroblasts from Oral Cancer Promotes Cancer Cell Migration and Invasion by Targeting Wnt10b , 2016, Journal of biochemical and molecular toxicology.

[14]  E. Giannoni,et al.  Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation , 2015 .

[15]  T. Boonmars,et al.  Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. , 2015, Asian Pacific journal of cancer prevention : APJCP.

[16]  Chao Li,et al.  Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications. , 2014, Experimental and molecular pathology.

[17]  C. Subimerb,et al.  Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[18]  R. Stephens,et al.  Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility , 2013, Oncogene.

[19]  J. Urban,et al.  SerpinB2 Is Critical to Th2 Immunity against Enteric Nematode Infection , 2013, The Journal of Immunology.

[20]  A. Dietz,et al.  Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. , 2013, Cancer research.

[21]  Yixuan Hou,et al.  MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer. , 2012, The international journal of biochemistry & cell biology.

[22]  I. Petersen,et al.  Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells , 2012, Histochemistry and Cell Biology.

[23]  P. Cirri,et al.  Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression , 2012, Cancer and Metastasis Reviews.

[24]  Michael C. Ostrowski,et al.  Reprogramming of the Tumor Microenvironment by Stromal Pten-regulated miR-320 , 2011, Nature Cell Biology.

[25]  G. Muto,et al.  Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer , 2011, Oncogene.

[26]  T. Litman,et al.  High expression of miR‐21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer , 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[27]  A. Loukas,et al.  Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos. , 2011, Acta tropica.

[28]  Jeung-Hoon Lee,et al.  Plasminogen activator inhibitor-2 (PAI-2) secreted from activated mast cells induces α-smooth muscle actin (α-SMA) expression in dermal fibroblasts. , 2011, Journal of dermatological science.

[29]  C. Dumur,et al.  Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma , 2011, Current opinion in gastroenterology.

[30]  K. Junker,et al.  Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer , 2011, Journal of Cancer Research and Clinical Oncology.

[31]  A. Suhrbier,et al.  SerpinB2 deficiency modulates Th1/Th2 responses after schistosome infection , 2010, Parasite immunology.

[32]  H. Nielsen,et al.  High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients , 2010, Clinical & Experimental Metastasis.

[33]  Kristian Pietras,et al.  Hallmarks of cancer: interactions with the tumor stroma. , 2010, Experimental cell research.

[34]  E. Gaudio,et al.  Cholangiocarcinoma: update and future perspectives. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[35]  Y. Abiko,et al.  Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker , 2010, Molecular Cancer.

[36]  O. Ogunwobi,et al.  Intrahepatic cholangiocarcinoma progression: prognostic factors and basic mechanisms. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[37]  T. Suthiphongchai,et al.  Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma. , 2009, Oncology reports.

[38]  H. Prats,et al.  The VEGF IRESes are differentially susceptible to translation inhibition by miR-16. , 2009, RNA.

[39]  A. Mannermaa,et al.  Frequent gene dosage alterations in stromal cells of epithelial ovarian carcinomas , 2006, International journal of cancer.

[40]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[41]  Y. Numata,et al.  Epithelial and stromal genetic instability contributes to genesis of colorectal adenomas , 2005, Gut.

[42]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[43]  Suzuki Yasuo,et al.  Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. , 1996 .

[44]  T. Terada,et al.  Alpha-smooth muscle actin-positive stromal cells in cholangiocarcinomas, hepatocellular carcinomas and metastatic liver carcinomas. , 1996, Journal of hepatology.